Anthropometrics and Vital

Parameters		Placebo	*B. coagulans*	P value Δ
		(N=20)	MTCC 5856
			(N=18)
Weight (Kg)
	Baseline (Day 0)	72.2 ± 12.8	68.8 ± 13.6	0.598
	End of Study (Day 30)	71.8 ± 13.5	69.4 ± 14	0.604
	Change From Baseline to Day 30	p = 0.429	p = 0.390	0.968
BMI (kg/m²)
	Baseline (Day 0)	24.6 ± 2.7	24.5 ± 3	0.731
	End of Study (Day 30)	24.4 ± 2.9	24.3 ± 3.3	0.869
	Change From Baseline to Day 30	p = 0.381	p = 0.353	0.897
Heart Rate (BPM)
	Baseline (Day 0)	68.3 ± 7.5	68.9 ± 8.4	0.839
	End of Study (Day 30)	65.9 ± 6.8	69.2 ± 8.6	0.193
	Change From Baseline to Day 30	p = 0.157	p = 0.486	0.159
Systolic Blood Pressure (mmHg)
	Baseline (Day 0)	100.4 ± 10.3	104.0 ± 9.4	0.253
	End of Study (Day 30)	104.9 ± 10.4	100.0 ± 9.0	0.127
	Change From Baseline to Day 30	p = 0.023	p = 0.100	0.006
Diastolic Blood Pressure (mmHg)
	Baseline (Day 0)	66.5 ± 7.6	68.4 ± 6.7	0.428
	End of Study (Day 30)	67.4 ± 7.6	69.0 ± 7.9	0.547
	Change From Baseline to Day 30	p = 0.590	p = 0.852	0.796

Table 2: Anthropometrics and Vital Signs for All Participants at Baseline and after 30 Days of Supplementation with B. coagulans MTCC 5856 or Placebo BPM, beats per minute; mmHg, millimeter of mercury; kg, kilograms; BMI, body mass index; kg/m², kilograms per square meter. Δ Between-group comparisons were made using the unpaired Student’s t-test. Within-group comparisons were made using the paired Student’s t-test. Probability (p) values ≤0.05 are statistically significant.